Literature DB >> 2168433

Calcitonin receptors on circulating normal human lymphocytes.

J J Body1, F Glibert, S Nejai, G Fernandez, A Van Langendonck, A Borkowski.   

Abstract

Circulating human lymphocytes possess specific and functional receptors for calcitriol and PTH. We sought to determine if they also possessed receptors for calcitonin (CT), the third classical calciotropic hormone. We isolated blood mononuclear cells from healthy volunteers to separate monocytes, total lymphocytes, and T-lymphocytes; the purity of the three cell populations was more than 90%, 95%, and 85%, respectively. Salmon CT (sCT) was labeled by the chloramine-T method (SA, 254 muCi/micrograms) without loss of biological activity. We found saturable (16 h at 8 C), specific, high affinity binding sites for [125I]sCT on unstimulated lymphocytes. As for CT receptors on other cells, binding of [125I]sCT was poorly reversible. Binding specificity was demonstrated by the total absence of competing effect of several unrelated hormones; human CT and CT gene-related peptide competed much less efficiently than sCT for the binding sites, whereas PDN-21 had no effect. When plotted according to the method of Scatchard, binding data on the mixed population of T- and B-lymphocytes showed an apparent Kd (mean +/- SD) of 2.9 +/- 1.0 x 10(-10) M (n = 34), with an estimation of 91-8338 (median, 1971) binding sites/cell. The data were repeatedly compatible with an aspect of positive cooperativity between the binding sites, as confirmed by a Hill coefficient greater than 1 (1.18 +/- 0.13). However, this aspect of positive cooperativity in CT binding was not observed on isolated T-lymphocytes (Hill coefficient, 0.96 +/- 0.08; n = 9; P less than 0.001 vs. the mixed population of lymphocytes). CT did not induce a significant increase in cAMP levels, but regulation of receptor concentration was demonstrated by the finding of down-regulation of CT-binding sites after sCT or human CT preincubation. In summary, we have found saturable, specific, high affinity receptors for CT on unstimulated normal human T-lymphocytes, which could, thus, be target sites for CT action on bone metabolism or on the immune system.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2168433     DOI: 10.1210/jcem-71-3-675

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  8 in total

1.  Enhancement of 1,25-dihydroxyvitamin D3-mediated suppression of experimental autoimmune encephalomyelitis by calcitonin.

Authors:  Bryan R Becklund; Donald W Hansen; Hector F Deluca
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-12       Impact factor: 11.205

Review 2.  The neuroendocrine-immune axis.

Authors:  F Homo-Delarche; M Dardenne
Journal:  Springer Semin Immunopathol       Date:  1993

3.  Calcitonin inhibits production of immunoglobulins, rheumatoid factor and interleukin-1 by mononuclear cells from patients with rheumatoid arthritis.

Authors:  S Aida; M Okawa-Takatsuji; S Aotsuka; K Shimoji; R Yokohari
Journal:  Ann Rheum Dis       Date:  1994-04       Impact factor: 19.103

4.  Calcitonin receptors on neoplastic mononuclear cells cultured from a human giant-cell tumor of the sacrum.

Authors:  A Maeda; H Matsui; M Kanamori; K Yudoh; H Tsuji
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

5.  Regulation of lymphocyte calcitonin receptors by interleukin-1 and interleukin-6.

Authors:  J J Body; G Fernandez; M Lacroix; P Vandenbussche; J Content
Journal:  Calcif Tissue Int       Date:  1994-08       Impact factor: 4.333

6.  A novel ligand of calcitonin receptor reveals a potential new sensor that modulates programmed cell death.

Authors:  Sgb Furness; D L Hare; A Kourakis; A M Turnley; P J Wookey
Journal:  Cell Death Discov       Date:  2016-10-10

7.  Calcitonin receptor expression in medullary thyroid carcinoma.

Authors:  Virginia Cappagli; Catarina Soares Potes; Luciana Bueno Ferreira; Catarina Tavares; Catarina Eloy; Rossella Elisei; Manuel Sobrinho-Simões; Peter J Wookey; Paula Soares
Journal:  PeerJ       Date:  2017-09-13       Impact factor: 2.984

8.  The calcitonin and glucocorticoids combination: mechanistic insights into their class-effect synergy in experimental arthritis.

Authors:  Adam Al-Kashi; Trinidad Montero-Melendez; Niloufar Moradi-Bidhendi; James P Gilligan; Nozer Mehta; Mauro Perretti
Journal:  PLoS One       Date:  2013-02-05       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.